May 2006
Volume 47, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2006
Inhibition of Laser–Induced Choroidal Neovascularization in Mice Using Antisense Oligonucleotides Directed Against HIF–1 or HIF–1ß
Author Affiliations & Notes
  • T.W. Lauer
    Ophthalmology, The Johns Hopkins University, Baltimore, MD
  • S.F. Hackett
    Ophthalmology, The Johns Hopkins University, Baltimore, MD
  • R. Formica
    Ophthalmology, The Johns Hopkins University, Baltimore, MD
  • K. Yokoi
    Ophthalmology, The Johns Hopkins University, Baltimore, MD
  • N.H. Khu
    Ophthalmology, The Johns Hopkins University, Baltimore, MD
  • S. Henry
    Isis Pharmaceuticals, Carlsbad, CA
  • P.A. Campochiaro
    Ophthalmology, The Johns Hopkins University, Baltimore, MD
  • Footnotes
    Commercial Relationships  T.W. Lauer, None; S.F. Hackett, None; R. Formica, None; K. Yokoi, None; N.H. Khu, None; S. Henry, Isis Pharmaceuticals, E; P.A. Campochiaro, Isis Pharmaceuticals, F.
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science May 2006, Vol.47, 1428. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      T.W. Lauer, S.F. Hackett, R. Formica, K. Yokoi, N.H. Khu, S. Henry, P.A. Campochiaro; Inhibition of Laser–Induced Choroidal Neovascularization in Mice Using Antisense Oligonucleotides Directed Against HIF–1 or HIF–1ß . Invest. Ophthalmol. Vis. Sci. 2006;47(13):1428.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Antisense oligonucleotides provide a useful way to explore the role of particular genes in disease pathogenesis. Hypoxia–inducible factor (HIF) is a heterodimeric transcription factor, with HIF–1α and HIF–1ß subunits, that regulates expression of many proangiogenic factors. In this study, we used antisense oligonucleotides generated against the mRNAs of HIF–1α and HIF–1ß to investigate the role of each subunit in the development of choroidal neovascularization (CNV) after rupture of Bruch's membrane.

Methods: : Immediately after laser disruption of Bruch’s membrane, mice were given a 1 µl intravitreous injection of scrambled control oligo, anti–HIF–1α oligo, anti–HIF–1ß oligo, or saline. After 14 days, mice were perfused with fluorescein–labeled dextran and the area of CNV at rupture sites was measured on choroidal flat mounts.

Results: : In paired comparisons, both anti–HIF–1α and anti–HIF–1ß oligos significantly inhibited the development of CNV compared to the control oligo or saline. Compared to injection of saline, injection of 14 µg of the anti–HIF–1α or anti–HIF–1ß oligo decreased the mean area of CNV by 55.0% or 32.3%, respectively. Injection of 1 µg of the anti–HIF–1ß oligo decreased the mean area of CNV by 60.0% compared to injection of 1 µg of control oligo. Comparison of saline and control oligo groups showed no significant difference in CNV area.

Conclusions: : These data indicate that both HIF–1α and HIF–1ß play a role in the development of CNV at Bruch's membrane rupture sites and provide potential targets for therapeutic intervention.

Keywords: choroid: neovascularization • neovascularization 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×